EHR-Based Strategies to Improve Outcomes in Familial Hypercholesterolemia

Project: Research project

Project Details

Description

PROJECT SUMMARY/ABSTRACT Familial hypercholesterolemia (FH) is a relatively common genetic disorder characterized by elevated plasma low-density lipoprotein cholesterol (LDL-C) and a dramatically increased lifetime risk for premature atherosclerotic cardiovascular disease (ASCVD). Available data suggest substantial under treatment of individuals with FH, and it is estimated that
StatusNot started

Funding

  • National Heart, Lung, and Blood Institute: $638,566.00
  • National Heart, Lung, and Blood Institute: $653,490.00
  • National Heart, Lung, and Blood Institute: $520,081.00
  • National Heart, Lung, and Blood Institute: $675,136.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.